Literature DB >> 28900005

Shocking superantigens promote establishment of bacterial infection.

Nikolai Siemens1,2, Anna Norrby-Teglund3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28900005      PMCID: PMC5617317          DOI: 10.1073/pnas.1713451114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

1.  Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens.

Authors:  A Norrby-Teglund; N Ihendyane; R Kansal; H Basma; M Kotb; J Andersson; L Hammarström
Journal:  Clin Infect Dis       Date:  2000-11-10       Impact factor: 9.079

Review 2.  Superantigens: microbial agents that corrupt immunity.

Authors:  Martin Llewelyn; Jon Cohen
Journal:  Lancet Infect Dis       Date:  2002-03       Impact factor: 25.071

3.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Authors:  R Kaul; A McGeer; A Norrby-Teglund; M Kotb; B Schwartz; K O'Rourke; J Talbot; D E Low
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

4.  Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.

Authors:  Anna Linnér; Jessica Darenberg; Jan Sjölin; Birgitta Henriques-Normark; Anna Norrby-Teglund
Journal:  Clin Infect Dis       Date:  2014-06-13       Impact factor: 9.079

5.  A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

Authors:  Martina Sanderson-Smith; David M P De Oliveira; Julien Guglielmini; David J McMillan; Therese Vu; Jessica K Holien; Anna Henningham; Andrew C Steer; Debra E Bessen; James B Dale; Nigel Curtis; Bernard W Beall; Mark J Walker; Michael W Parker; Jonathan R Carapetis; Laurence Van Melderen; Kadaba S Sriprakash; Pierre R Smeesters
Journal:  J Infect Dis       Date:  2014-05-05       Impact factor: 5.226

6.  The Hypervariable region of Streptococcus pyogenes M protein escapes antibody attack by antigenic variation and weak immunogenicity.

Authors:  Jonas Lannergård; Mattias C U Gustafsson; Johan Waldemarsson; Anna Norrby-Teglund; Margaretha Stålhammar-Carlemalm; Gunnar Lindahl
Journal:  Cell Host Microbe       Date:  2011-08-18       Impact factor: 21.023

7.  Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.

Authors:  A Norrby-Teglund; R Kaul; D E Low; A McGeer; D W Newton; J Andersson; U Andersson; M Kotb
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

Review 8.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  Sequence variability is correlated with weak immunogenicity in Streptococcus pyogenes M protein.

Authors:  Jonas Lannergård; Bodil M Kristensen; Mattias C U Gustafsson; Jenny J Persson; Anna Norrby-Teglund; Margaretha Stålhammar-Carlemalm; Gunnar Lindahl
Journal:  Microbiologyopen       Date:  2015-07-15       Impact factor: 3.139

10.  Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner.

Authors:  Katherine J Kasper; Joseph J Zeppa; Adrienne T Wakabayashi; Stacey X Xu; Delfina M Mazzuca; Ian Welch; Miren L Baroja; Malak Kotb; Ewa Cairns; P Patrick Cleary; S M Mansour Haeryfar; John K McCormick
Journal:  PLoS Pathog       Date:  2014-05-29       Impact factor: 6.823

View more
  2 in total

1.  Analysis of host-pathogen gene association networks reveals patient-specific response to streptococcal and polymicrobial necrotising soft tissue infections.

Authors:  Sanjeevan Jahagirdar; Lorna Morris; Nirupama Benis; Oddvar Oppegaard; Mattias Svenson; Ole Hyldegaard; Steinar Skrede; Anna Norrby-Teglund; Vitor A P Martins Dos Santos; Edoardo Saccenti
Journal:  BMC Med       Date:  2022-05-04       Impact factor: 11.150

Review 2.  The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections.

Authors:  Patience Shumba; Srikanth Mairpady Shambat; Nikolai Siemens
Journal:  Toxins (Basel)       Date:  2019-06-11       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.